Trump Admin Reclassifies Medical Marijuana
Failed to add items
Add to Cart failed.
Add to Wish List failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
Trump Admin Reclassifies Medical Marijuana
-
Narrated by:
-
By:
Trump Administration Reclassifies Medical Marijuana, Opening Doors for Industry
The Trump administration has reclassified medical marijuana from a Schedule one drug to Schedule three, marking the first federal nod to its medical value in fifty years. This move, signed by acting Attorney General Todd Blanche, treats marijuana as having moderate risk, similar to ketamine or Tylenol with codeine. Local cannabis industry leaders, such as Mariah Bond from Euphoria Wellness and Eugenio Garcia from Cannabis Now magazine, welcome this change, citing tax relief and potential for medical research as significant benefits. The reclassification is seen as a step towards cannabis going mainstream federally and at the state level.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/a3d9b6efbdbbfa29